Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1995 Jul;96(1):520–527. doi: 10.1172/JCI118064

Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus.

D A Ehrmann 1, J Sturis 1, M M Byrne 1, T Karrison 1, R L Rosenfield 1, K S Polonsky 1
PMCID: PMC185226  PMID: 7615824

Abstract

The increased prevalence of non-insulin-dependent diabetes mellitus (NIDDM) among women with polycystic ovary syndrome (PCOS) has been ascribed to the insulin resistance characteristic of PCOS. This study was undertaken to determine the role of defects in insulin secretion as well as familial factors to the predisposition to NIDDM seen in PCOS. We studied three groups of women: PCOS with a family history of NIDDM (PCOS FHx POS; n = 11), PCOS without a family history of NIDDM (PCOS FHx NEG; n = 13), and women without PCOS who have a family history of NIDDM (NON-PCOS FHx POS; n = 8). Beta cell function was evaluated during a frequently sampled intravenous glucose tolerance test, by a low dose graded glucose infusion, and by the ability of the beta cell to be entrained by an oscillatory glucose infusion. PCOS FHx POS women were significantly less likely to demonstrate appropriate beta cell compensation for the degree of insulin resistance. The ability of the beta cell to entrain, as judged by the spectral power for insulin secretion rate, was significantly reduced in PCOS FHx POS subjects. In conclusion, a history of NIDDM in a first-degree relative appears to define a subset of PCOS subjects with a greater prevalence of insulin secretory defects. The risk of developing NIDDM imparted by insulin resistance in PCOS may be enhanced by these defects in insulin secretion.

Full text

PDF
527

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barnes R. B., Rosenfield R. L., Burstein S., Ehrmann D. A. Pituitary-ovarian responses to nafarelin testing in the polycystic ovary syndrome. N Engl J Med. 1989 Mar 2;320(9):559–565. doi: 10.1056/NEJM198903023200904. [DOI] [PubMed] [Google Scholar]
  2. Bergman R. N. Lilly lecture 1989. Toward physiological understanding of glucose tolerance. Minimal-model approach. Diabetes. 1989 Dec;38(12):1512–1527. doi: 10.2337/diab.38.12.1512. [DOI] [PubMed] [Google Scholar]
  3. Bergman R. N., Phillips L. S., Cobelli C. Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose. J Clin Invest. 1981 Dec;68(6):1456–1467. doi: 10.1172/JCI110398. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Burghen G. A., Givens J. R., Kitabchi A. E. Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease. J Clin Endocrinol Metab. 1980 Jan;50(1):113–116. doi: 10.1210/jcem-50-1-113. [DOI] [PubMed] [Google Scholar]
  5. Byrne M. M., Sturis J., Clément K., Vionnet N., Pueyo M. E., Stoffel M., Takeda J., Passa P., Cohen D., Bell G. I. Insulin secretory abnormalities in subjects with hyperglycemia due to glucokinase mutations. J Clin Invest. 1994 Mar;93(3):1120–1130. doi: 10.1172/JCI117064. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Byrne M. M., Sturis J., Polonsky K. S. Insulin secretion and clearance during low-dose graded glucose infusion. Am J Physiol. 1995 Jan;268(1 Pt 1):E21–E27. doi: 10.1152/ajpendo.1995.268.1.E21. [DOI] [PubMed] [Google Scholar]
  7. Chang R. J., Laufer L. R., Meldrum D. R., DeFazio J., Lu J. K., Vale W. W., Rivier J. E., Judd H. L. Steroid secretion in polycystic ovarian disease after ovarian suppression by a long-acting gonadotropin-releasing hormone agonist. J Clin Endocrinol Metab. 1983 May;56(5):897–903. doi: 10.1210/jcem-56-5-897. [DOI] [PubMed] [Google Scholar]
  8. Ciaraldi T. P., el-Roeiy A., Madar Z., Reichart D., Olefsky J. M., Yen S. S. Cellular mechanisms of insulin resistance in polycystic ovarian syndrome. J Clin Endocrinol Metab. 1992 Aug;75(2):577–583. doi: 10.1210/jcem.75.2.1322430. [DOI] [PubMed] [Google Scholar]
  9. Dahlgren E., Janson P. O., Johansson S., Lapidus L., Lindstedt G., Tengborn L. Hemostatic and metabolic variables in women with polycystic ovary syndrome. Fertil Steril. 1994 Mar;61(3):455–460. [PubMed] [Google Scholar]
  10. Dahlgren E., Johansson S., Lindstedt G., Knutsson F., Odén A., Janson P. O., Mattson L. A., Crona N., Lundberg P. A. Women with polycystic ovary syndrome wedge resected in 1956 to 1965: a long-term follow-up focusing on natural history and circulating hormones. Fertil Steril. 1992 Mar;57(3):505–513. doi: 10.1016/s0015-0282(16)54892-4. [DOI] [PubMed] [Google Scholar]
  11. Diamond M. P., Simonson D. C., DeFronzo R. A. Menstrual cyclicity has a profound effect on glucose homeostasis. Fertil Steril. 1989 Aug;52(2):204–208. [PubMed] [Google Scholar]
  12. Dunaif A., Graf M., Mandeli J., Laumas V., Dobrjansky A. Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia. J Clin Endocrinol Metab. 1987 Sep;65(3):499–507. doi: 10.1210/jcem-65-3-499. [DOI] [PubMed] [Google Scholar]
  13. Dunaif A., Green G., Futterweit W., Dobrjansky A. Suppression of hyperandrogenism does not improve peripheral or hepatic insulin resistance in the polycystic ovary syndrome. J Clin Endocrinol Metab. 1990 Mar;70(3):699–704. doi: 10.1210/jcem-70-3-699. [DOI] [PubMed] [Google Scholar]
  14. Dunaif A., Mandeli J., Fluhr H., Dobrjansky A. The impact of obesity and chronic hyperinsulinemia on gonadotropin release and gonadal steroid secretion in the polycystic ovary syndrome. J Clin Endocrinol Metab. 1988 Jan;66(1):131–139. doi: 10.1210/jcem-66-1-131. [DOI] [PubMed] [Google Scholar]
  15. Dunaif A., Segal K. R., Futterweit W., Dobrjansky A. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes. 1989 Sep;38(9):1165–1174. doi: 10.2337/diab.38.9.1165. [DOI] [PubMed] [Google Scholar]
  16. Dunaif A., Segal K. R., Shelley D. R., Green G., Dobrjansky A., Licholai T. Evidence for distinctive and intrinsic defects in insulin action in polycystic ovary syndrome. Diabetes. 1992 Oct;41(10):1257–1266. doi: 10.2337/diab.41.10.1257. [DOI] [PubMed] [Google Scholar]
  17. Eaton R. P., Allen R. C., Schade D. S., Erickson K. M., Standefer J. Prehepatic insulin production in man: kinetic analysis using peripheral connecting peptide behavior. J Clin Endocrinol Metab. 1980 Sep;51(3):520–528. doi: 10.1210/jcem-51-3-520. [DOI] [PubMed] [Google Scholar]
  18. Ehrmann D. A., Rosenfield R. L., Barnes R. B., Brigell D. F., Sheikh Z. Detection of functional ovarian hyperandrogenism in women with androgen excess. N Engl J Med. 1992 Jul 16;327(3):157–162. doi: 10.1056/NEJM199207163270304. [DOI] [PubMed] [Google Scholar]
  19. Elkind-Hirsch K. E., Valdes C. T., Malinak L. R. Insulin resistance improves in hyperandrogenic women treated with Lupron. Fertil Steril. 1993 Oct;60(4):634–641. doi: 10.1016/s0015-0282(16)56213-x. [DOI] [PubMed] [Google Scholar]
  20. Faber O. K., Binder C., Markussen J., Heding L. G., Naithani V. K., Kuzuya H., Blix P., Horwitz D. L., Rubenstein A. H. Characterization of seven C-peptide antisera. Diabetes. 1978;27 (Suppl 1):170–177. doi: 10.2337/diab.27.1.s170. [DOI] [PubMed] [Google Scholar]
  21. Henriksen J. E., Alford F., Handberg A., Vaag A., Ward G. M., Kalfas A., Beck-Nielsen H. Increased glucose effectiveness in normoglycemic but insulin-resistant relatives of patients with non-insulin-dependent diabetes mellitus. A novel compensatory mechanism. J Clin Invest. 1994 Sep;94(3):1196–1204. doi: 10.1172/JCI117436. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Holte J., Bergh T., Berne C., Berglund L., Lithell H. Enhanced early insulin response to glucose in relation to insulin resistance in women with polycystic ovary syndrome and normal glucose tolerance. J Clin Endocrinol Metab. 1994 May;78(5):1052–1058. doi: 10.1210/jcem.78.5.8175959. [DOI] [PubMed] [Google Scholar]
  23. Janssen R. C., Bogardus C., Takeda J., Knowler W. C., Thompson D. B. Linkage analysis of acute insulin secretion with GLUT2 and glucokinase in Pima Indians and the identification of a missense mutation in GLUT2. Diabetes. 1994 Apr;43(4):558–563. doi: 10.2337/diab.43.4.558. [DOI] [PubMed] [Google Scholar]
  24. Jialal I., Naiker P., Reddi K., Moodley J., Joubert S. M. Evidence for insulin resistance in nonobese patients with polycystic ovarian disease. J Clin Endocrinol Metab. 1987 May;64(5):1066–1069. doi: 10.1210/jcem-64-5-1066. [DOI] [PubMed] [Google Scholar]
  25. Kahn S. E., Prigeon R. L., McCulloch D. K., Boyko E. J., Bergman R. N., Schwartz M. W., Neifing J. L., Ward W. K., Beard J. C., Palmer J. P. Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function. Diabetes. 1993 Nov;42(11):1663–1672. doi: 10.2337/diab.42.11.1663. [DOI] [PubMed] [Google Scholar]
  26. Lillioja S., Mott D. M., Spraul M., Ferraro R., Foley J. E., Ravussin E., Knowler W. C., Bennett P. H., Bogardus C. Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians. N Engl J Med. 1993 Dec 30;329(27):1988–1992. doi: 10.1056/NEJM199312303292703. [DOI] [PubMed] [Google Scholar]
  27. Lillioja S., Mott D. M., Zawadzki J. K., Young A. A., Abbott W. G., Knowler W. C., Bennett P. H., Moll P., Bogardus C. In vivo insulin action is familial characteristic in nondiabetic Pima Indians. Diabetes. 1987 Nov;36(11):1329–1335. doi: 10.2337/diab.36.11.1329. [DOI] [PubMed] [Google Scholar]
  28. Martin B. C., Warram J. H., Krolewski A. S., Bergman R. N., Soeldner J. S., Kahn C. R. Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study. Lancet. 1992 Oct 17;340(8825):925–929. doi: 10.1016/0140-6736(92)92814-v. [DOI] [PubMed] [Google Scholar]
  29. Moll G. W., Jr, Rosenfield R. L., Helke J. H. Estradiol-testosterone binding interactions and free plasma estradiol under physiological conditions. J Clin Endocrinol Metab. 1981 May;52(5):868–874. doi: 10.1210/jcem-52-5-868. [DOI] [PubMed] [Google Scholar]
  30. Moller D. E., Flier J. S. Insulin resistance--mechanisms, syndromes, and implications. N Engl J Med. 1991 Sep 26;325(13):938–948. doi: 10.1056/NEJM199109263251307. [DOI] [PubMed] [Google Scholar]
  31. O'Meara N. M., Blackman J. D., Ehrmann D. A., Barnes R. B., Jaspan J. B., Rosenfield R. L., Polonsky K. S. Defects in beta-cell function in functional ovarian hyperandrogenism. J Clin Endocrinol Metab. 1993 May;76(5):1241–1247. doi: 10.1210/jcem.76.5.8496316. [DOI] [PubMed] [Google Scholar]
  32. O'Meara N. M., Sturis J., Van Cauter E., Polonsky K. S. Lack of control by glucose of ultradian insulin secretory oscillations in impaired glucose tolerance and in non-insulin-dependent diabetes mellitus. J Clin Invest. 1993 Jul;92(1):262–271. doi: 10.1172/JCI116560. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. O'Rahilly S., Spivey R. S., Holman R. R., Nugent Z., Clark A., Turner R. C. Type II diabetes of early onset: a distinct clinical and genetic syndrome? Br Med J (Clin Res Ed) 1987 Apr 11;294(6577):923–928. doi: 10.1136/bmj.294.6577.923. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Peiris A. N., Mueller R. A., Struve M. F., Smith G. A., Kissebah A. H. Relationship of androgenic activity to splanchnic insulin metabolism and peripheral glucose utilization in premenopausal women. J Clin Endocrinol Metab. 1987 Jan;64(1):162–169. doi: 10.1210/jcem-64-1-162. [DOI] [PubMed] [Google Scholar]
  35. Polonsky K. S., Given B. D., Hirsch L. J., Tillil H., Shapiro E. T., Beebe C., Frank B. H., Galloway J. A., Van Cauter E. Abnormal patterns of insulin secretion in non-insulin-dependent diabetes mellitus. N Engl J Med. 1988 May 12;318(19):1231–1239. doi: 10.1056/NEJM198805123181903. [DOI] [PubMed] [Google Scholar]
  36. Polonsky K. S., Licinio-Paixao J., Given B. D., Pugh W., Rue P., Galloway J., Karrison T., Frank B. Use of biosynthetic human C-peptide in the measurement of insulin secretion rates in normal volunteers and type I diabetic patients. J Clin Invest. 1986 Jan;77(1):98–105. doi: 10.1172/JCI112308. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Rosenfield R. L., Barnes R. B., Cara J. F., Lucky A. W. Dysregulation of cytochrome P450c 17 alpha as the cause of polycystic ovarian syndrome. Fertil Steril. 1990 May;53(5):785–791. [PubMed] [Google Scholar]
  38. Schumacher M. C., Hasstedt S. J., Hunt S. C., Williams R. R., Elbein S. C. Major gene effect for insulin levels in familial NIDDM pedigrees. Diabetes. 1992 Apr;41(4):416–423. doi: 10.2337/diab.41.4.416. [DOI] [PubMed] [Google Scholar]
  39. Shapiro E. T., Tillil H., Polonsky K. S., Fang V. S., Rubenstein A. H., Van Cauter E. Oscillations in insulin secretion during constant glucose infusion in normal man: relationship to changes in plasma glucose. J Clin Endocrinol Metab. 1988 Aug;67(2):307–314. doi: 10.1210/jcem-67-2-307. [DOI] [PubMed] [Google Scholar]
  40. Sonnenberg G. E., Hoffman R. G., Mueller R. A., Kissebah A. H. Splanchnic insulin dynamics and secretion pulsatilities in abdominal obesity. Diabetes. 1994 Mar;43(3):468–477. doi: 10.2337/diab.43.3.468. [DOI] [PubMed] [Google Scholar]
  41. Sturis J., Polonsky K. S., Shapiro E. T., Blackman J. D., O'Meara N. M., van Cauter E. Abnormalities in the ultradian oscillations of insulin secretion and glucose levels in type 2 (non-insulin-dependent) diabetic patients. Diabetologia. 1992 Jul;35(7):681–689. doi: 10.1007/BF00400263. [DOI] [PubMed] [Google Scholar]
  42. Sturis J., Van Cauter E., Blackman J. D., Polonsky K. S. Entrainment of pulsatile insulin secretion by oscillatory glucose infusion. J Clin Invest. 1991 Feb;87(2):439–445. doi: 10.1172/JCI115015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Valdes C. T., Elkind-Hirsch K. E. Intravenous glucose tolerance test-derived insulin sensitivity changes during the menstrual cycle. J Clin Endocrinol Metab. 1991 Mar;72(3):642–646. doi: 10.1210/jcem-72-3-642. [DOI] [PubMed] [Google Scholar]
  44. Van Cauter E., Mestrez F., Sturis J., Polonsky K. S. Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance. Diabetes. 1992 Mar;41(3):368–377. doi: 10.2337/diab.41.3.368. [DOI] [PubMed] [Google Scholar]
  45. Warram J. H., Martin B. C., Krolewski A. S., Soeldner J. S., Kahn C. R. Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents. Ann Intern Med. 1990 Dec 15;113(12):909–915. doi: 10.7326/0003-4819-113-12-909. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES